We are live on ! Find out more
PODD icon

Insulet

467 hedge funds and large institutions have $16.3B invested in Insulet in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 167 increasing their positions, 161 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 36

4% more funds holding

Funds holding: 449467 (+18)

5% more capital invested

Capital invested by funds: $15.6B → $16.3B (+$725M)

4% more repeat investments, than reductions

Existing positions increased: 167 | Existing positions reduced: 161

0.72% less ownership

Funds ownership: 103.31%102.59% (-0.72%)

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

40% less call options, than puts

Call options by funds: $36.6M | Put options by funds: $61.1M

Holders
467
Holders Change
+18
Holders Change %
+4.01%
% of All Funds
8.04%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
56
Increased
167
Reduced
161
Closed
36
Calls
$36.6M
Puts
$61.1M
Net Calls
-$24.5M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$109M +$1.29M +5,147 +1%
Norges Bank
27
Norges Bank
Norway
$105M -$13.6M -54,329 -11%
Northern Trust
28
Northern Trust
Illinois
$101M -$1.52M -6,056 -1%
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$101M +$16.2M +64,487 +17%
American Century Companies
30
American Century Companies
Missouri
$96M +$3.5M +13,971 +3%
Thrivent Financial for Lutherans
31
Thrivent Financial for Lutherans
Minnesota
$90.6M +$18.3K +73 +0%
Legal & General Group
32
Legal & General Group
United Kingdom
$89M -$4.93M -19,668 -5%
UBS AM
33
UBS AM
Illinois
$86.9M +$3.11M +12,421 +3%
BG
34
Bellevue Group
Switzerland
$85.8M -$3.1M -12,382 -3%
Fisher Asset Management
35
Fisher Asset Management
Washington
$82.6M -$4.64M -18,527 -5%
Amundi
36
Amundi
France
$80.3M +$5.94M +23,701 +8%
Aberdeen Group
37
Aberdeen Group
United Kingdom
$78.5M +$18.9M +75,275 +28%
William Blair & Company
38
William Blair & Company
Illinois
$74.3M +$4M +15,959 +5%
FCM
39
Frontier Capital Management
Massachusetts
$71.1M -$2.67M -10,677 -3%
Baird Financial Group
40
Baird Financial Group
Wisconsin
$70.1M +$2.87M +11,460 +4%
Federated Hermes
41
Federated Hermes
Pennsylvania
$69.7M -$2.58M -10,302 -3%
Swiss National Bank
42
Swiss National Bank
Switzerland
$68.9M +$50.1K +200 +0.1%
Lord, Abbett & Co
43
Lord, Abbett & Co
New Jersey
$68.5M +$64.9M +259,089 +652%
Westfield Capital Management
44
Westfield Capital Management
Massachusetts
$64.9M +$987K +3,941 +1%
AllianceBernstein
45
AllianceBernstein
Tennessee
$57M +$3.89M +15,525 +7%
N
46
Nuveen
North Carolina
$54.1M -$1.63M -6,527 -3%
CS
47
Credit Suisse
Switzerland
$53.5M -$6.57M -26,228 -10%
Fidelity International
48
Fidelity International
Bermuda
$52M -$4.99M -19,922 -8%
Charles Schwab
49
Charles Schwab
California
$50.3M -$42.3M -168,721 -44%
Sumitomo Mitsui Trust Group
50
Sumitomo Mitsui Trust Group
Japan
$46.1M +$43.6K +174 +0.1%

PODD Hedge Fund Activity: Q3 2022 in Review

467 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2022, worth a combined $16.3B — up 4.6% from $15.6B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new PODD positions and 36 closed out — a net gain of 20 holders — while 167 added to existing stakes and 161 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $64.9M. The largest seller was Marshall Wace, cutting an estimated $108M.

  • 467 institutional investors held Insulet (PODD) as of Q3 2022, up from 449 in Q2 2022.
  • Funds reported $16.3B of Insulet stock for Q3 2022, up 4.6% quarter-over-quarter.
  • 56 funds opened new Insulet positions in Q3 2022 and 36 closed out, a net change of +20 holders.
  • The largest Insulet buyer in Q3 2022 was Lord, Abbett & Co, an estimated $64.9M added.
  • The largest Insulet seller in Q3 2022 was Marshall Wace, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2022.